Innovative and Advanced Technologies for Microbial Identification Now Available
Oct 05 2012
Accugenix, the newest addition to the Charles River Endotoxin and Microbial Detection (EMD) portfolio of products and services, focused on providing exceptional QC solutions and is the premier provider of FDA-registered, cGMP-compliant contract microbial testing services.
With the addition of Accugenix, Charles River is now able to provide you with a full line of microbial identification solutions, including:
Genotypic Identification - Our sequence-based genetic microbial identification services, AccuGENX-ID®, are considered the industry’s “gold standard” methods of choice for moderate and complex applications, such as high-risk manufacturing, sterility failures, final product releases and testing for sterile fill facilities.
Proteotypic Identification - Accugenix offers AccuPRO-ID®, a proteotypic method based on MALDI-TOF mass spectrometry technology.
Sequence Analysis - Our AccuBLAST® service addresses the needs of customers utilizing in-house microbial identification systems (MicroSEQ®) who require a higher level of expertise in data analysis, report interpretation, library coverage for accurate microbial identification.
Strain Typing - As a complement to our sequence-based microbial identification services, Accugenix offers our AccuGENX-ST™ multi and single locus sequence typing (MLST, SLST) service, as well as automated ribotyping (BacRib) for strain-level characterization and tracking of bacterial isolates.
To learn more about our newly expanded microbial testing services, please click here or contact us at askcharlesriver@crl.com.